Both in Pharmaceuticals
Supernus Pharmaceuticals vs Phibro Animal Health
Over the past year SUPN returned −49.5% and PAHC returned −13.2%; their daily moves had a correlation of 0.16.
SUPN −49.5% PAHC −13.2%Growth of $1, one year, split-adjusted
| Metric | SUPN | PAHC |
|---|---|---|
| Price | $28.15 | $37.65 |
| Market cap | $1.64B | $1.53B |
| Today | −32.85% | −2.81% |
| 1 month | −34.2% | +1.2% |
| 6 months | −42.8% | −33.1% |
| Year to date | −43.4% | +0.8% |
| 1 year | — | −10.5% |
| Revenue growth (YoY) | +18.0% | +4.8% |
| Gross margin | 88.1% | 33.9% |
| Net margin | 9.2% | 5.5% |
| P/E (TTM) | — | 15.3× |
| Price / sales | 1.9× | 1.0× |
| Net cash | $359.5M | -$650.8M |
| Dividend yield | 28.88% | 1.27% |
| Volatility (60d) | 86.0% | 30.2% |
| Short % of float | 7.3% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).